A district court in New Jersey ruled that the plaintiff lacked standing for certain claims, but there is a chance the case ...
Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
A smiling baby with an array of baby care products in the foreground. Number of Hedge Fund Holders: 81 Johnson & Johnson ...
Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...
AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...
Johnson & Johnson reports financial results Wednesday Jan. 22 before market open. The results could provide a lift for the healthcare sector and Dow Jones Industrial Average. The healthcare sector ...
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
Some might describe Johnson & Johnson's business as boring, but sometimes, that's not such a bad thing. Selling pharmaceutical products is a steady and reliable business even when the economy is ...
NEW BRUNSWICK, N.J. and BEDMINSTER, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced ...
In this article, we are going to take a look at where Johnson & Johnson ... reasons to include health stocks in a retirement portfolio is their defensive nature. Health care is a necessity ...
Health care is a necessity ... beating its benchmark by 150 percentage points (see more details here). Johnson & Johnson (NYSE:JNJ) researches and develops, manufactures, and sells various ...
In this article, we are going to take a look at where Johnson & Johnson (NYSE ... One of the most compelling reasons to include health stocks in a retirement portfolio is their defensive nature.